Table 5 Top 20 prediction results from the retrospective analysis on DrugBank 5.1.0
No | SMD A | BioD B | *Event Type | Evidence |
|---|---|---|---|---|
1 | Glisoxepide | Nesiritide | 1 | N.A |
2 | Vorapaxar | Tocilizumab | 2 | DrugBank5.1.8 |
3 | 6-O-benzylguanine | Tocilizumab | 2 | DrugBank5.1.8 |
4 | Raltitrexed | Protein S human | 3 | DrugBank5.1.8 |
5 | Domoic Acid | Tocilizumab | 2 | N.A |
6 | Talazoparib | Tocilizumab | 2 | N.A |
7 | Glisoxepide | Insulin | 3 | DrugBank5.1.8 |
8 | Glisoxepide | Insulin pork | 3 | DrugBank5.1.8 |
9 | Vorapaxar | Siltuximab | 1 | DrugBank5.1.8 |
10 | Domoic Acid | Siltuximab | 1 | N.A |
11 | Zolmitriptan | Tocilizumab | 1 | DrugBank5.1.8 |
12 | Desonide | Tocilizumab | 1 | N.A |
13 | Glisoxepide | Insulin glulisine | 3 | DrugBank5.1.8 |
14 | 6-O-benzylguanine | Siltuximab | 1 | DrugBank5.1.8 |
15 | Fluocinolone acetonide | Tocilizumab | 1 | DrugBank5.1.8 |
16 | Fluocinonide | Tocilizumab | 1 | DrugBank5.1.8 |
17 | Desonide | Siltuximab | 1 | N.A |
18 | Glisoxepide | Mecasermin | 3 | DrugBank5.1.8 |
19 | Glisoxepide | Insulin detemir | 3 | DrugBank5.1.8 |
20 | Glisoxepide | Insulin lispro | 3 | DrugBank5.1.8 |